ABBV news

• AbbVie's Dividend Keeps Climbing. Is It Still a Buy for Income Investors?

  24/7 Wall Street · Oct 17, 2026
• If a Stock Market Crash Is Coming, History Says These 3 ETFs Are the Smartest Buys

  Fool - Investing News · Oct 17, 2026
• Forget High-Yield Traps: AbbVie Is the Dividend King to Buy and Hold Through Any Rate Cycle

  The Motley Fool · Oct 17, 2026
• AbbVie Inc. $ABBV Shares Sold by Banque Pictet & Cie SA

  Defense World · Oct 17, 2026
• SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  GuruFocus · Oct 17, 2026
• SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026

  PRNewsWire · Oct 17, 2026
• Here's How Many Shares of AbbVie You'd Need for $5,000 in Yearly Dividends

  The Motley Fool · Oct 16, 2026
• AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 15, 2026
• AbbVie Inc. $ABBV Position Reduced by Cliftonlarsonallen Wealth Advisors LLC

  Defense World · Oct 15, 2026
• Which Pharma Stock Looks More Attractive: Sanofi or AbbVie?

  Zacks Investment Research · Oct 14, 2026
• AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

  Zacks Investment Research · Oct 14, 2026
• Blockbuster Drugs Come and Go. These 5 Pharma Dividend Stocks Keep Paying

  24/7 Wall Street · Oct 14, 2026
• A Look at AbbVie Inc (ABBV) After 2.4% Decline -- GF Value $222.10 vs Price $274.36

  GuruFocus · Oct 13, 2026
• AbbVie vs. Novo Nordisk: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 13, 2026
• 5 High-Yield Dividend Stocks That Could Turn October's Market Weakness Into Income

  24/7 Wall Street · Oct 13, 2026
• Netflix, DocuSign And A Health Care Stock On CNBC's ‘Final Trades'

  Benzinga · Oct 13, 2026
• AbbVie (NYSE:ABBV) Reaches New 52-Week High – Here’s Why

  Defense World · Oct 13, 2026
• AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?

  The Motley Fool · Oct 12, 2026
• AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts

  Zacks Investment Research · Oct 12, 2026
• Biotech's Rebound Reality: Surging M&A Deals Meet Deep Retail Skepticism

  ETF Trends · Oct 12, 2026
• Will Skyrizi & Rinvoq Drive AbbVie's Top-Line Growth in Q3?

  Zacks Investment Research · Oct 12, 2026
• Prediction: AbbVie's Next Billion-Dollar Opportunity Is Taking Shape

  24/7 Wall Street · Oct 12, 2026
• Which Pharmaceuticals ETF Is the Better Buy: iShares’ IHE or Invesco’s PJP?

  Fool - Investing News · Oct 11, 2026
• Which Healthcare ETF Is the Better Buy: Fidelity’s Broad FHLC or Invesco’s Biotech-Focused PBE?

  Fool - Investing News · Oct 11, 2026
• New SKYRIZI® (risankizumab-rzaa) and RINVOQ® (upadacitinib) Data Demonstrate Disease Control for Patients Living With Inflammatory Bowel Disease

  PRNewsWire · Oct 11, 2026
• 5 Dividend Stocks for Retirees Who Want More Than Just a Big Yield

  24/7 Wall Street · Oct 11, 2026
• AbbVie's Dividend Yield Is at Its Lowest Level Since 2018. Here's Why the Stock Is Still a Great Pick for Income Investors Anyway.

  The Motley Fool · Oct 11, 2026
• A Stock Market Crash Is Coming By the End of 2027, According to Some Economists. Here Are 2 Stocks to Buy Before That Happens

  Fool - Investing News · Oct 9, 2026
• Treasury Bills or Dividend Stocks? The Retirement Income Math May Surprise You

  247 Wallst · Oct 9, 2026
• Cantor Fitzgerald Lifts Price Targets on Four Pharma Giants Amid Mixed Growth Outlooks

  24/7 Wall Street · Oct 9, 2026

Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.